Takara Bio (TSE:4974) Construction In Progress : 円11,712 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Construction In Progress?

Takara Bio's quarterly construction in progress declined from Sep. 2023 (円10,546 Mil) to Dec. 2023 (円10,383 Mil) but then increased from Dec. 2023 (円10,383 Mil) to Mar. 2024 (円11,712 Mil).

Takara Bio's annual construction in progress increased from Mar. 2022 (円1,519 Mil) to Mar. 2023 (円2,102 Mil) and increased from Mar. 2023 (円2,102 Mil) to Mar. 2024 (円11,712 Mil).

Takara Bio Construction In Progress Historical Data

The historical data trend for Takara Bio's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Construction In Progress Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Construction In Progress

Get a 7-Day Free Trial

85.00

3,756.00

1,519.00

2,102.00

11,712.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															2,102.00	2,457.00	10,546.00	10,383.00	11,712.00

Takara Bio Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines